NewGenIvf Group Limited (NASDAQ:NIVF) Sees Large Drop in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) saw a large decrease in short interest in October. As of October 30th, there was short interest totaling 125,342 shares, a decrease of 94.9% from the October 15th total of 2,470,389 shares. Based on an average trading volume of 934,259 shares, the days-to-cover ratio is presently 0.1 days. Currently, 16.5% of the shares of the company are short sold.

NewGenIvf Group Price Performance

Shares of NewGenIvf Group stock traded down $0.02 during trading hours on Thursday, hitting $0.28. The company’s stock had a trading volume of 353,493 shares, compared to its average volume of 759,133. The business has a 50 day moving average price of $10.30 and a two-hundred day moving average price of $330.08. NewGenIvf Group has a 12-month low of $0.22 and a 12-month high of $7,404.48.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings data on Wednesday, October 7th. The company reported ($111.54) earnings per share for the quarter, missing analysts’ consensus estimates of $581.76 by ($693.30). The firm had revenue of $0.96 million during the quarter, compared to analysts’ expectations of $20.10 million. As a group, analysts expect that NewGenIvf Group will post 1365.44 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, November 2nd. Wall Street Zen cut shares of NewGenIvf Group to a “strong sell” rating in a research note on Saturday, October 24th. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company currently has an average rating of “Sell”.

About NewGenIvf Group

NewGenIvf Group Limited (NASDAQ:NIVF) is a fertility-services company focused on assisted reproductive technology and related medical care. Through its NewGen IVF operations, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), fertility assessments and fertility-preservation procedures. Its service offering also includes egg and sperm freezing, embryo-related services, genetic testing and donor-program support, subject to applicable medical and regulatory requirements.